Phase 3 Drug Trial for Advanced Breast Cancer by AstraZeneca Shows Good Results in First-line Treatment
News
AstraZeneca has revealed positive data from its FALCON Phase 3 clinical trial for metastatic breast cancer. More specicically, the trial evaluated Faslodex (fulvestrant) versus Arimidex (anastrozole) as a treatment option for metastatic or locally-advanced breast cancer, ... Read more